Spero Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A.
CEOEsther Rajavelu
CEOEsther Rajavelu
Employees32
Employees32
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees32
Employees32
SPRO Key Statistics
Market cap130.43M
Market cap130.43M
Price-Earnings ratio-2.91
Price-Earnings ratio-2.91
Dividend yield—
Dividend yield—
Average volume260.48K
Average volume260.48K
High today—
High today—
Low today—
Low today—
Open price$2.29
Open price$2.29
Volume0.00
Volume0.00
52 Week high$3.22
52 Week high$3.22
52 Week low$0.5052
52 Week low$0.5052
Stock Snapshot
Spero Therapeutics(SPRO) stock is priced at $2.30, giving the company a market capitalization of 130.43M. It carries a P/E multiple of -2.91.
On 2025-12-18, Spero Therapeutics(SPRO) shares started trading at $2.29, with intraday highs of — and lows of —.
Trading volume for Spero Therapeutics(SPRO) stock has reached 0, versus its average volume of 260.48K.
The stock's 52-week range extends from a low of $0.51 to a high of $3.22.
The stock's 52-week range extends from a low of $0.51 to a high of $3.22.
People also own
Based on the portfolios of people who own SPRO. This list is generated using Robinhood data, and it’s not a recommendation.